This Avalyn Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avalyn Pharma
Connect Biopharma
Hemab Therapeutics Holdings
Circle

Avalyn Pharma

AVLN

0.00

Connect Biopharma

CNTB

0.00

Hemab Therapeutics Holdings

COAG

0.00

Circle

CRCL

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Keybanc initiated coverage on Circle Internet Group (NYSE:CRCL) with a Sector Weight rating. Circle Internet shares closed at $113.12 on Friday. See how other analysts view this stock.
  • Goldman Sachs analyst Richard Law initiated coverage on Hemab Therapeutics Holdings Inc (NASDAQ:COAG) with a Buy rating and announced a price target of $36. Hemab Therapeutics shares closed at $25.89 on Friday. See how other analysts view this stock.
  • Morgan Stanley analyst Judah Frommer initiated coverage on Avalyn Pharma Inc (NASDAQ:AVLN) with an Overweight rating and announced a price target of $53. Avalyn Pharma shares closed at $28.84 on Friday. See how other analysts view this stock.
  • Canaccord Genuity analyst Edward Nash initiated coverage on Connect Biopharma Holdings Ltd (NASDAQ:CNTB) with a Buy rating and announced a price target of $6. Connect Biopharma shares closed at $2.35 on Friday. See how other analysts view this stock.
  • Guggenheim analyst Seamus Fernandez initiated coverage on Avalyn Pharma Inc (NASDAQ:AVLN) with a Buy rating and announced a price target of $80. Avalyn Pharma shares closed at $28.84 on Friday. See how other analysts view this stock.

Considering buying AVLN stock? Here’s what analysts think:

Photo via Shutterstock